Healthcare Case Study
Type 2 Diabetes Journey & Treatment Satisfaction (US Adults)
What the client needed
120 US adults (35–70) with Type 2 diabetes on prescription therapy: how they moved from diagnosis to treatment, and how satisfied they are now.
Why it was hard
Medical screening that doesn't spook people, personal health questions that need trust, a 25-minute survey, and incidence-driven costs to control.
How we ran it
- Privacy-first sequencing: Engagement first, sensitive items later — drop-off falls measurably.
- Staged screening: Diagnosis and treatment confirmed progressively, not in one interrogation block.
- Plain-language questionnaire: Reviewed for readability across education levels.
- Diagnosis validation: Consistency checks plus open-ends to catch false claims.
Results
Target: US adults 35–70, diagnosed Type 2, on prescription therapy.
Completes: 120. Incidence: 18%. LOI: 25 minutes. Field: 7 days.
On spec, on time. Adherence barriers and unmet needs from this study went straight into the client's patient-support redesign.